Entecavir 500microgram tablets
NHS hospitals in England used £56,938,628 of indicative cost of Entecavir 500microgram tablets in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 26.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Entecavir 500microgram tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Entecavir 500microgram tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| King's College Hpl Nhs Foundation Trust | £6,389,076 |
| Royal Free London Nhs Foundation Trust | £4,540,592 |
| Guy's & St Thomas' Nhs Foundation Trust | £3,923,364 |
| Manchester University Nhs Ft | £3,135,405 |
| Univ Hpl B/Ham Nhs Foundation Trust | £2,994,787 |
| Barts Health Nhs Trust | £2,793,299 |
| University College London Foundation Tr | £2,014,492 |
| Lewisham And Greenwich Nhs Trust | £1,913,338 |
| University Hpls Of Leicester Nhs Trust | £1,639,913 |
| St George's Univ Hosps Foundation Nhst | £1,574,865 |
The primary-care picture
Entecavir is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Entecavir medicine page.